Page last updated: 2024-10-21

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Cerebral Infarction, Middle Cerebral Artery

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with Cerebral Infarction, Middle Cerebral Artery in 5 studies

alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid: An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies.

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Sharma, H1
Reeta, KH1
Sharma, U1
Suri, V1
Singh, S1
Guo, Z1
Cao, G1
Yang, H1
Zhou, H1
Li, L1
Cao, Z1
Yu, B1
Kou, J1
Chi, OZ1
Hunter, C1
Liu, X1
Weiss, HR1
Pinteaux, E1
Rothwell, NJ1
Boutin, H1
Cuthill, DJ1
Fowler, JH1
McCulloch, J1
Dewar, D1

Other Studies

5 other studies available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Cerebral Infarction, Middle Cerebral Artery

ArticleYear
AMPA receptor modulation through sequential treatment with perampanel and aniracetam mitigates post-stroke damage in experimental model of ischemic stroke.
    Naunyn-Schmiedeberg's archives of pharmacology, 2023, Volume: 396, Issue:12

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anti-Inflammatory Agents; Infarct

2023
A combination of four active compounds alleviates cerebral ischemia-reperfusion injury in correlation with inhibition of autophagy and modulation of AMPK/mTOR and JNK pathways.
    Journal of neuroscience research, 2014, Volume: 92, Issue:10

    Topics: Adenine; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Autophagy; Brain; Brain

2014
Effects of exogenous excitatory amino acid neurotransmitters on blood-brain barrier disruption in focal cerebral ischemia.
    Neurochemical research, 2009, Volume: 34, Issue:7

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Aminoisobutyric Acids; Animals; Blood-Brai

2009
Neuroprotective actions of endogenous interleukin-1 receptor antagonist (IL-1ra) are mediated by glia.
    Glia, 2006, Apr-01, Volume: 53, Issue:5

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Astrocytes; Brain Ischemia; Cell

2006
Different patterns of axonal damage after intracerebral injection of malonate or AMPA.
    Experimental neurology, 2006, Volume: 200, Issue:2

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amyloid beta-Protein Precursor; Analysis o

2006